[PATIENT WITH PEPTIC ULCER DISEASE].

Area of Science:

• Gastroenterology
• Internal Medicine
• Microbiology

Background:

• Peptic ulcer disease (PUD) arises from an imbalance in the digestive tract's mucosal defense and aggressive factors.
• Key external triggers for PUD include Helicobacter pylori infection and the use of non-steroidal anti-inflammatory drugs (NSAIDs) and acetylsalicylic acid (ASA).
• Dyspeptic symptoms are a frequent reason for primary care consultations, necessitating clear diagnostic pathways.

Purpose of the Study:

• To outline diagnostic and management strategies for peptic ulcer disease.
• To define appropriate testing and treatment protocols for Helicobacter pylori infection in patients presenting with dyspepsia.

Main Methods:

• Recommends Urea Breath Test or stool antigen testing for H. pylori in patients under 50 without alarm symptoms.
• Mandates endoscopic examination for patients over 50 or those with alarm symptoms.
• Outlines first-line eradication therapies including sequential or triple therapy (PPI, amoxicillin, metronidazole).

Main Results:

• H. pylori infection should be treated upon confirmation.
• Eradication therapy is followed by a control test for H. pylori four weeks post-treatment.
• Age and alarm symptoms dictate the diagnostic approach (testing vs. endoscopy).

Conclusions:

• Timely diagnosis and targeted H. pylori eradication are crucial for managing peptic ulcer disease.
• Adherence to recommended diagnostic and therapeutic guidelines ensures effective PUD management.
• Follow-up testing confirms successful eradication, preventing recurrence.